Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Non-small cell lung cancer-smokers or non-smokers, does it matter?

Lung cancer (Amsterdam, Netherlands) - 1 Mar 2009

Barlési Fabrice, Nanni-Metellus Isabelle, Breen David, Fina Frédéric, Astoul Philippe, Martin Pierre-Marie

Abstract excerpt

Besides epidermal growth factor receptor (EGFR) gene mutations, clinical factors such as smoking status have been identified as predictors for survival for NSCLC patients treated with EGFR-tyrosine kinase inhibitors (TKI). However, the biological screening for EGFR gene mutations is not routinely available everywhere. Therefore, the question arises if the decision to treat patients with EGFR-TKI should be based...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to DNA, Neoplasm

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Erlotinib Hydrochloride

Share to Follow-Up Studies

Share to Lung Neoplasms

Share to Protein Kinase Inhibitors

Share to Quinazolines

Source

Identifiers

PMID: 18789554
DOI: 10.1016/j.lungcan.2008.08.001

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Non-small cell lung cancer-smokers or non-smokers, does it matter?PMID 18789554Read ↗

Lung cancer in 'never-smokers': beyond EGFR mutations and EGFR-TK inhibitors.Semantic proximity Read ↗

EGFR MUTATIONS IN NON-SMALL CELL LUNG CANCER: LOCAL EPIDEMIOLOGY AND CLINICAL IMPORTANCE.Semantic proximity Read ↗

Republished: lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy?Semantic proximity Read ↗

Lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy?Semantic proximity Read ↗

[Lung cancer in smokers and never-smokers].Semantic proximity Read ↗

Lung cancer in never smokers: change of a mindset in the molecular era.Semantic proximity Read ↗

EGFR Mutation Status and First-Line Treatment in Patients with Stage III/IV Non–Small Cell Lung Cancer in Germany: An Observational StudySemantic proximity Read ↗

EGFR mutations in non-small-cell lung cancer among smokers and non-smokers: a meta-analysis.Semantic proximity Read ↗

Epidermal growth factor receptor mutation study for 5 years, in a population of patients with non-small cell lung cancer.Semantic proximity Read ↗

Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer: results and open issues.Semantic proximity Read ↗

Impact of smoking status on EGFR-TKI efficacy for advanced non-small-cell lung cancer in EGFR mutants: a meta-analysis.Semantic proximity Read ↗

Epidermal Growth Factor Recetor mutation study for 5 years, in a population of patients with non-small cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.